KR20070116192A - 항혈전제 - Google Patents

항혈전제 Download PDF

Info

Publication number
KR20070116192A
KR20070116192A KR1020077027348A KR20077027348A KR20070116192A KR 20070116192 A KR20070116192 A KR 20070116192A KR 1020077027348 A KR1020077027348 A KR 1020077027348A KR 20077027348 A KR20077027348 A KR 20077027348A KR 20070116192 A KR20070116192 A KR 20070116192A
Authority
KR
South Korea
Prior art keywords
ser
gly
thr
seq
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077027348A
Other languages
English (en)
Korean (ko)
Inventor
프랭크 씨. 바론
마이클 엔. 블랙번
지오라 지. 퓨어스타인
존 알. 투미
Original Assignee
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스미스클라인 비참 코포레이션 filed Critical 스미스클라인 비참 코포레이션
Publication of KR20070116192A publication Critical patent/KR20070116192A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020077027348A 2000-05-15 2000-10-05 항혈전제 Ceased KR20070116192A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57143400A 2000-05-15 2000-05-15
US09/571,434 2000-05-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020027015403A Division KR20030034071A (ko) 2000-05-15 2000-10-05 항혈전제

Publications (1)

Publication Number Publication Date
KR20070116192A true KR20070116192A (ko) 2007-12-06

Family

ID=24283688

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020077027348A Ceased KR20070116192A (ko) 2000-05-15 2000-10-05 항혈전제
KR1020027015403A Ceased KR20030034071A (ko) 2000-05-15 2000-10-05 항혈전제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020027015403A Ceased KR20030034071A (ko) 2000-05-15 2000-10-05 항혈전제

Country Status (20)

Country Link
US (1) US20050037006A1 (https=)
EP (2) EP1825864A3 (https=)
JP (1) JP2004516236A (https=)
KR (2) KR20070116192A (https=)
CN (2) CN100339132C (https=)
AT (1) ATE345816T1 (https=)
AU (2) AU7858400A (https=)
BR (1) BR0015872A (https=)
CA (1) CA2411369A1 (https=)
CZ (1) CZ20023778A3 (https=)
DE (1) DE60032029T2 (https=)
ES (1) ES2277597T3 (https=)
HU (1) HU225874B1 (https=)
IL (1) IL152831A0 (https=)
MX (1) MXPA02011385A (https=)
NO (1) NO20025463L (https=)
NZ (1) NZ522632A (https=)
PL (1) PL360060A1 (https=)
WO (1) WO2001087339A1 (https=)
ZA (1) ZA200209265B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438913B1 (en) 2002-03-20 2020-05-06 University of Maryland, Baltimore A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
US8980952B2 (en) 2002-03-20 2015-03-17 University Of Maryland, Baltimore Methods for treating brain swelling with a compound that blocks a non-selective cation channel
EP1802313B1 (en) 2004-09-18 2010-11-03 University of Maryland, Baltimore Therapeutic agents trageting the ncca-atp channel and methods of use thereof
JP5085326B2 (ja) 2004-09-18 2012-11-28 ユニバーシティ オブ メリーランド，ボルチモア ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
US9511075B2 (en) 2007-01-12 2016-12-06 The University Of Maryland, Baltimore Targeting NCCA-ATP channel for organ protection following ischemic episode
CA2691199C (en) 2007-06-22 2017-09-12 Marc J. Simard Inhibitors of ncca-atp channels for therapy
ES2595638T3 (es) 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
JP2011504371A (ja) * 2007-11-21 2011-02-10 オレゴン ヘルス アンド サイエンス ユニバーシティー 抗第ｘｉ因子モノクローナル抗体およびその使用方法
GB201121513D0 (en) * 2011-12-14 2012-01-25 Cambridge Entpr Ltd Thrombin-binding antibody molecules and uses thereof
US9518128B2 (en) 2011-12-14 2016-12-13 Janssen Pharmaceuticals, Inc. Thrombin-binding antibody molecules
IL267519B2 (en) * 2016-12-23 2025-04-01 Novartis Ag Factor XI/XIA for use in the prevention, treatment, management, or reduction of the risk of stroke or thromboembolism in a patient with end-stage renal disease
EP3617316A4 (en) 2017-04-27 2020-12-23 Chugai Seiyaku Kabushiki Kaisha COAGULATION FACTOR IX WITH IMPROVED PHARMACOKINETICS
US20240018503A1 (en) * 2017-04-27 2024-01-18 Chugai Seiyaku Kabushiki Kaisha Coagulation factor ix with improved pharmacokinetics
CN115448985A (zh) * 2021-06-08 2022-12-09 上海循曜生物科技有限公司 新型抗栓抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049655C (en) * 1990-09-17 1996-11-12 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
WO2000007626A1 (en) * 1998-08-07 2000-02-17 Smithkline Beecham Corporation Use of anti-coagulation factor antibodies as long-lasting protective agents
US6624295B1 (en) * 1998-08-28 2003-09-23 Genentech, Inc. Human anti-factor IX/IXa antibodies

Also Published As

Publication number Publication date
HUP0301804A2 (hu) 2003-08-28
AU7858400A (en) 2001-11-26
MXPA02011385A (es) 2004-01-26
EP1282444A4 (en) 2004-06-30
ATE345816T1 (de) 2006-12-15
US20050037006A1 (en) 2005-02-17
PL360060A1 (en) 2004-09-06
NZ522632A (en) 2005-05-27
CA2411369A1 (en) 2001-11-22
NO20025463D0 (no) 2002-11-14
AU2000278584B2 (en) 2006-11-16
IL152831A0 (en) 2003-06-24
EP1825864A2 (en) 2007-08-29
CN1501812A (zh) 2004-06-02
BR0015872A (pt) 2004-08-03
NO20025463L (no) 2003-01-09
HU225874B1 (en) 2007-11-28
WO2001087339A1 (en) 2001-11-22
EP1282444B1 (en) 2006-11-22
ES2277597T3 (es) 2007-07-16
KR20030034071A (ko) 2003-05-01
JP2004516236A (ja) 2004-06-03
HUP0301804A3 (en) 2005-12-28
DE60032029D1 (de) 2007-01-04
CN100339132C (zh) 2007-09-26
EP1825864A3 (en) 2007-09-12
DE60032029T2 (de) 2007-05-31
ZA200209265B (en) 2003-10-22
CN101134107A (zh) 2008-03-05
EP1282444A1 (en) 2003-02-12
CZ20023778A3 (cs) 2003-08-13

Similar Documents

Publication Publication Date Title
KR100553629B1 (ko) 혈전증치료에유용한항응고제
EP1282444B1 (en) Antithrombotic agents
AU2000278584A1 (en) Antithrombotic agents
US20040146511A1 (en) Antithrombotic agents
EP0941345A2 (en) Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
US20060057140A1 (en) Anticoagulant agents useful in treatment of thrombosis
US20070190059A1 (en) Antithrombotic agents
HK1029513B (en) Anticoagulant humanised antibodies against factor ix, for use in the treatment of thrombosis
HK1109339A (en) Antithrombotic agents
HK1107932A (en) Anticoagulant agents useful in treatment of thrombosis
CA2243236A1 (en) Anticoagulant agents useful in treatment of thrombosis

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20071123

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20071224

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080205

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20081030

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20080205

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I